Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Tables)

Interim Segment Information (Tables)

6 Months Ended

Sep. 30, 2012

Interim Segment Information [Abstract]


	Three Months Ended September 30, 2012
(in thousands)	Westell			CNS			Unallocated			Total
Revenue	$	9,854		$	68		$	—		$	9,922
Cost of goods sold		6,405			69			—			6,474

Gross profit		3,449			(1	)		—			3,448
Gross margin		35.0	%		(1.5	)%		—			34.8	%
Operating expenses:
Sales and marketing		1,831			(7	)		—			1,824
Research and development		1,436			498			—			1,934
General and administrative		1,046			540			1,077			2,663
Restructuring		57			—			—			57
Intangible amortization		210			1			—			211

Operating expenses		4,580			1,032			1,077			6,689

Operating income (loss) from continuing operations	$	(1,131	)	$	(1,033	)		(1,077	)		(3,241	)

Other income (expense)								7			7

Income (loss) from continuing operations before tax								(1,070	)		(3,234	)
Income tax benefit (expense)								1,059			1,059

Net income (loss) from continuing operations							$	(11	)	$	(2,175	)


	Three Months Ended September 30, 2011
(in thousands)	Westell			CNS			Unallocated			Total
Revenue	$	10,401		$	10,327		$	—		$	20,728
Cost of goods sold		6,469			8,038			—			14,507

Gross profit		3,932			2,289			—			6,221
Gross margin		37.8	%		22.2	%		—			30.0	%
Operating expenses:
Sales and marketing		1,446			249			—			1,695
Research and development		1,342			649			—			1,991
General and administrative		604			256			905			1,765
Restructuring		—			32			—			32
Intangible amortization		137			1			—			138

Operating expenses		3,529			1,187			905			5,621

Operating income (loss) from continuing operations	$	403		$	1,102			(905	)		600

Gain on CNS asset sale								46			46
Other income (expense)								77			77
Interest (expense)								(5	)		(5	)

Income (loss) from continuing operations before tax								(787	)		718
Income tax benefit (expense)								1,852			1,852

Net income (loss) from continuing operations							$	1,065		$	2,570


	Six Months Ended September 30, 2012
(in thousands)	Westell			CNS			Unallocated			Total
Revenue	$	19,272		$	1,180		$	—		$	20,452
Cost of goods sold		13,050			158			—			13,208

Gross profit		6,222			1,022			—			7,244
Gross margin		32.3	%		86.6	%		—			35.4	%
Operating expenses:
Sales and marketing		3,706			2			—			3,708
Research and development		2,885			876			—			3,761
General and administrative		2,294			542			2,408			5,244
Restructuring		149			—			—			149
Intangible amortization		418			2			—			420

Operating expenses		9,452			1,422			2,408			13,282

Operating income (loss) from continuing operations	$	(3,230	)	$	(400	)		(2,408	)		(6,038	)

Other income (expense), net								91			91

Income (loss) from continuing operations before tax								(2,317	)		(5,947	)
Income tax benefit (expense)								2,032			2,032

Net income (loss) from continuing operations							$	(285	)	$	(3,915	)


	Six Months Ended September 30, 2011
(in thousands)	Westell			CNS			Unallocated			Total
Revenue	$	25,246		$	18,683		$	—		$	43,929
Cost of goods sold		14,806			14,536			—			29,342

Gross profit		10,440			4,147			—			14,587
Gross margin		41.4	%		22.2	%		—			33.2	%
Operating expenses:
Sales and marketing		2,928			766			—			3,694
Research and development		2,606			1,462			—			4,068
General and administrative		1,422			551			1,945			3,918
Restructuring		—			277			—			277
Intangible amortization		275			2			—			277

Operating expenses		7,231			3,058			1,945			12,234

Operating income (loss) from continuing operations	$	3,209		$	1,089			(1,945	)		2,353

Gain on CNS asset sale								31,654			31,654
Other income (expenses)								95			95
Interest (expense)								(5	)		(5	)

Income (loss) from continuing operations before tax								29,799			34,097
Income tax benefit (expense)								(11,376	)		(11,376	)

Net income (loss) from continuing operations							$	18,423		$	22,721

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details